Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...

A potential breakthrough in spinal cord and optic nerve injury treatment

Click Here to Download the Full Report This is third-party provided content issued on behalf of NurExone Biologic Inc., please see full disclaimer here .

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

TSX this week The TSX has experienced a rocky week, marked by five consecutive sessions of declines. This downturn coincided with the unexpected resignation of Canada’s Finance Minister , Chrystia Freeland, just hours before she was scheduled to pre...

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Are you anticipating a calm market as the holidays approach? Think again. Astute investors and brokers recognize that this is their moment to excel. With the global economy constantly shifting, staying active is the smart move. Over the past week, some shareholde...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Buzz on the Bullboards: Tangible growth stocks

This week, Canada’s main stock index, the TSX , hit a record high thanks to gains in technology and bank stocks. What the “Buzz” Our Bullboards have up to 2 million pageviews a day. Get the inside scoop on conv...

Rick Rule's holiday gifts to grow wealth

The average Canadian will spend C$1478 this holiday season with 43 per cent of the budget spent with online platforms Rule likes the idea of gifting precious metals and company shares as an alternative to traditional Christmas gifts “Philanthropy with a...

Buzz on the Bullboards: Stocks to watch in volatile times.

This week, Canada’s main stock index, the TSX , hit another record high, supported by strong retail sales data and positive investor sentiment. However, the index quickly fell from grace following U.S. President-elect Donald Trump’s announ...

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

This past week, Canada’s main stock index, the TSX , hovered just shy of a new all-time high, buoyed by rising metal prices. However, the optimism was tempered as markets stuttered in response to renewed fears surrounding geopolitical tensions, particular...

The company revolutionizing access to care and natural remedies

The Market Online recently spoke with Liz Viccars, CEO of AJA Health and Wellness Inc. (TSXV:AJA) a company transforming healthcare with its total health access service offering telemedicine, diagnostics and specialized care via proprietary tech. Additionally, AJA Heal...
1 2 3 4 5 6 7 8 9 10 ...